Tuesday, October 16, 2018
 
 
Company News: Page (1) of 1 - 05/17/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
CytRx Corporation Highlights NantCell Inc's Aldoxorubicin Clinical Data to be Presented at the American Society of Clinical Oncology 2018 Annual Meeting
Data Show Aldoxorubicin, Alone or in Combination with Ifosfamide, Lacks Cardiotoxicity with Doxorubicin Equivalent Doses Beyond 1000 mg/mē
(May 17, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Pro AV,Post/Production,Presentors,Director,Business Issues,Presentation,Events, Inc.,Science,Lifestyle,Medical,Cancer,Other,
Related Sites: Digital Producer ,   Hollywood Industry ,   Audio Video Producer ,   Digital Post Production ,   Film Imaging ,   Presentation Master ,   Oceania ,   DMN Newswire ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   KNews Newsletter ,   Digital Media Net ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines